Functionally, research has revealed that the overexpression of CD9 and CD81 can inhibit HCC cell proliferation through the Krüppel-like factor 4 (KLF4)-CD9/CD81-Jun N-terminal kinase (JNK) signaling pathway. This evidence concerns the gene KLF4 and hepatocellular carcinoma.